Germany Daily Briefing

Mercedes-Benz (MBGAF) -3.31% and Volkswagen (VWAGY) -3.10% extended their correction on the twin pressures of deteriorating Chinese premium vehicle demand and rising EV transition costs. The SpaceX IPO crash covered in the German financial press (a -10% post-debut correction) dominated local investor attention but the auto-sector move is the macro tell. For DAX investors, the auto-pair's de-rating is structural — Q3 deliveries data from Shanghai will be the next hard catalyst. Names to watch: BMW and Mercedes Q3 China sales disclosure in early July.

Bayer (BAYRY) surged 3.18% on the day, contrasting sharply with the broader German technology and industrial selling. The chemicals and pharma sector gained +1.84% as a group, providing the index's essential positive offset. Bayer's move suggests the market is re-pricing downside risk from glyphosate litigation — the company's multi-billion liability overhang has compressed the stock well below net asset value estimates. If settlement terms emerge this summer, BAYRY could see a significant re-rating; the options market's implied vol on the name reflects acute binary risk that today's buyer seems willing to own.

Tehran's announcement of maritime fees for the Strait of Hormuz — with a 60-day implementation clock — introduces a new variable for European energy imports that are partly routed through the Gulf. While a full nuclear deal would suppress Brent crude, the interim Hormuz fee mechanism could support elevated energy transit costs in the near term. For Germany's energy-intensive industrial base (BASF, Covestro, Lanxess), any sustained energy cost pressure from Gulf logistics compounds the Energiewende transition challenge. Watch bund yields as the reflex indicator — any German energy supply concern typically pushes bunds higher (risk-off), which the ECB would need to weigh against its easing trajectory.